| Degradability of chitosan micro/nanoparticles for pulmonary drug delivery N Islam, I Dmour, MO Taha Heliyon 5, e01684, 2019 | 227 | 2019 |
| Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine I Al-masri, KM Mohammad, MO Taha journal of enzyme inhibition and medicinal chemistry 24 (5), 1061-1066, 2009 | 225 | 2009 |
| Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2 MM Hatmal, W Alshaer, MAI Al-Hatamleh, M Hatmal, O Smadi, MO Taha, ... Cells 9 (12), 2638, 2020 | 204 | 2020 |
| Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered, colon‐specific drug delivery systems K Aiedeh, MO Taha Archiv der pharmazie: an international journal pharmaceutical and medicinal …, 1999 | 180 | 1999 |
| Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral … K Aiedeh, MO Taha European Journal of Pharmaceutical Sciences 13 (2), 159-168, 2001 | 136 | 2001 |
| Stable Chitosan-Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles … R Saeed, I Dmour, M Taha Frontiers in Bioengineering and Biotechnology, 2020 | 122 | 2020 |
| Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for … MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ... Journal of medicinal chemistry 51 (7), 2062-2077, 2008 | 120 | 2008 |
| Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis MA Abbas, MO Taha, AM Disi, M Shomaf European journal of pharmacology 715 (1-3), 72-75, 2013 | 112 | 2013 |
| Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ... Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009 | 112 | 2009 |
| Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening MO Taha, Y Bustanji, AG Al-Bakri, AM Yousef, WA Zalloum, IM Al-Masri, ... Journal of Molecular Graphics and Modelling 25 (6), 870-884, 2007 | 106 | 2007 |
| Sodium lauryl sulfate impedes drug release from zinc-crosslinked alginate beads: Switching from enteric coating release into biphasic profiles MO Taha, W Nasser, A Ardakani, HS AlKhatib International Journal of Pharmaceutics 350 (1-2), 291-300, 2008 | 88 | 2008 |
| Enhanced drug encapsulation and extended release profiles of calcium–alginate nanoparticles by using tannic acid as a bridging cross-linking agent SR Abulateefeh, MO Taha Journal of microencapsulation 32 (1), 96-105, 2015 | 86 | 2015 |
| Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies MO Taha, M Habash, Z Al-Hadidi, A Al-Bakri, K Younis, S Sisan Journal of chemical information and modeling 51 (3), 647-669, 2011 | 85 | 2011 |
| Investigation of the active constituents of Portulaca oleraceae L.(Portulacaceae) growing in Jordan AN Rasheed, FU Afifi, M Shaedah, MO Taha Pakistan Journal of Pharmaceutical Sciences 17 (1), 37-45, 2004 | 85 | 2004 |
| Combining ligand-based pharmacophore modeling, quantitative structure− activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive … MO Taha, LA Dahabiyeh, Y Bustanji, H Zalloum, S Saleh Journal of medicinal chemistry 51 (20), 6478-6494, 2008 | 81 | 2008 |
| Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads A Al-Nadaf, GA Sheikha, MO Taha Bioorganic & medicinal chemistry 18 (9), 3088-3115, 2010 | 79 | 2010 |
| Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening IM Al‐masri, MK Mohammad, MO Taha ChemMedChem: Chemistry Enabling Drug Discovery 3 (11), 1763-1779, 2008 | 79 | 2008 |
| Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening MO Taha, N Atallah, AG Al-Bakri, C Paradis-Bleau, H Zalloum, KS Younis, ... Bioorganic & medicinal chemistry 16 (3), 1218-1235, 2008 | 76 | 2008 |
| Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration RA Khalaf, GA Sheikha, Y Bustanji, MO Taha European journal of medicinal chemistry 45 (4), 1598-1617, 2010 | 71 | 2010 |
| Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza … AM Abu Hammad, MO Taha Journal of chemical information and modeling 49 (4), 978-996, 2009 | 71 | 2009 |
Yasser BustanjiProfessor of Biochemistry and Clinical Chemistry, University of Sharjah在 ju.edu.jo 的電子郵件地址已通過驗證